SEPARATION AGREEMENT AND RELEASE OF CLAIMS (initially provided to Mr. Daniel on January 22, 2007) (provided to Mr. Daniel as amended on January 30, 2007) (provided to Mr. Daniel as further amended on February 1, 2007)Separation Agreement • May 8th, 2007 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
This Separation Agreement and Release of Claims (this “Separation Agreement”) is made by and between ADVENTRX Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Robert A. Daniel (“Mr. Daniel”) (collectively, the “Parties”).
ADVENTRX PHARMACEUTICALS, INC. CONSULTING AGREEMENTConsulting Agreement • May 8th, 2007 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”) is dated February 2, 2007 but will become effective (the “Effective Date”) as of and concurrent with the termination of the employment relationship of Robert A. Daniel , an individual resident of the State of California (“Consultant”), with ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
SECOND AMENDMENT TO OPTION AND LICENSE AGREEMENTOption and License Agreement • May 8th, 2007 • Adventrx Pharmaceuticals Inc • Pharmaceutical preparations
This Second Amendment to Option and License Agreement (this “Amendment”) is entered into effective as of January 25, 2007 (the “Effective Date”) by and between Adventrx Pharmaceuticals, Inc., a Delaware corporation formerly known as BioKeys Pharmaceuticals, Inc. and BioKeys, Inc. (the “Company”), and the University of Southern California, a California nonprofit corporation (“USC”).
